CRL vs IVVD · rev $2.00B vs rev $14.3M
Charles River Laboratories (CRL) versus Invivyd Inc. (IVVD) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Invivyd Inc. (IVVD) is a biotechnology company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported IVVD revenue for 2026-06-30 was $14.3M. Net income was -$44.4M. Revenue was up 3.9% from 2026-03-31 to 2026-06-30. IVVD currently screens at market cap $85.8M.
CRL currently screens at market cap $7.78B. IVVD currently screens at market cap $85.8M.
Not investment advice. Open the CRL and IVVD stock pages for the full models.
Not investment advice.